World Health Organization : Year 2001 ; Communicable Diseases and Emerging Infectious Diseases ; Tuberculosis, No. 2001.293: First Meeting of Global Working Group on TB/HIV 9-11 April 2001 Geneva, Switzerland

By D. Maher

Book Id: WPLBN0000197486
Format Type: PDF eBook:
File Size: 0.3 MB
Reproduction Date: 2005

Title:	World Health Organization : Year 2001 ; Communicable Diseases and Emerging Infectious Diseases ; Tuberculosis, No. 2001.293: First Meeting of Global Working Group on TB/HIV 9-11 April 2001 Geneva, Switzerland
Author:	D. Maher
Volume:
Language:	English
Subject:	Health., Public health, Wellness programs
Collections:	Medical Library Collection, World Health Collection
Historic Publication Date:
Publisher:	World Health Organization


Citation APA MLA Chicago Maher, B. D. (n.d.). World Health Organization : Year 2001 ; Communicable Diseases and Emerging Infectious Diseases ; Tuberculosis, No. 2001.293. Retrieved from http://gutenberg.cc/

Description
Medical Reference Publication

Excerpt
HIV fuels the TB epidemic, since HIV promotes progression to active TB in people with Mycobacterium tuberculosis infection, either acquired recently or in the past. The implication for TB control in high HIV prevalence populations is that prevention of HIV is crucial to control TB. Since TB is a leading cause of morbidity and mortality in people infected with HIV, the implication for HIV/AIDS programmes is that TB is a substantial part of HIV/AIDS care. However, so far TB and HIV programmes have largely pursued separate courses. It is necessary to improve the joint support of TB and HIV programmes for general health service providers, in responding effectively to the needs of people infected with HIV. Participants at the “Global DOTS Expansion Meeting” held in Cairo in November 2000, called for the establishment of a Global Working Group on TB/HIV. The goal of the Working Group is to reduce the burden of TB in high HIV prevalence populations. The Working Group, coordinated by WHO, is one of the six working groups established under the auspices of the Global Stop TB Partnership. This first meeting of the Working Group is the first step in harnessing and coordinating global efforts to provide a more effective response to the problem of TB in high HIV prevalence populations (TB/HIV).

Table of Contents
Contents Glossary of abbreviations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .5 Executive summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .7 Report 1 Background and meeting objectives . . . . . . . . . . . . . . . . . . . . . . . . . .11 2 The problem: the intersecting epidemics of TB and HIV . .13 3 The response so far . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .15 3.1 Field experiences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .15 3.1.1 Thailand . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .15 3.1.2 The ProTEST Initiative . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .16 3.2 WHO regional offices . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .19 3.3 UNAIDS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .22 3.4 TB and HIV programme interaction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .24 4 The way ahead . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .27 4.1 Examples of country plans for TB and HIV programme collaboration . . . . .27 4.1.1 South Africa . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .27 4.1.2 Uganda . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .28 4.1.3 Kenya . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .28 4.2 The ProTEST Initiative . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .28 4.3 TB and highly active antiretroviral treatment (HAART) . . . . . . . . . . . . . . . . . . . .29 4.4 The framework for effective TB control as a template for antiretroviral treatment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .30 4.5 WHO/UNAIDS strategic framework to decrease the burden of TB/HIV . . .31 4.6 From strategic framework to national implementation strategies . . . . . . . . . .34 4.7 Technical and financial partners’ perspectives . . . . . . . . . . . . . . . . . . . . . . . . . . . .34 5 Working group conclusions, recommendations and next steps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .37 5.1 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .37 5.2 Recommendations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .38 5.3 Next steps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .40 Annex 1 Meeting agenda . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .41 Annex 2 List of participants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .45 Annex 3 Progress reports on ProTEST projects: A) South Africa, B) Zambia, C) Malawi . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .53 Annex 4 ProTEST expansion: report back after small group discussions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .65